• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

First tonic-clonic seizure five hours after Ad26.COV2.S vaccination without acute brain lesion but long-term chorea.

作者信息

de Almeida Antonio-Carlos M, Fiorini Ana C, Scorza Fulvio A, Finsterer Josef

机构信息

Centro de Neurociências e Saúde da Mulher "Professor Geraldo Rodrigues de Lima", Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, SP, Brazil.

Programa de Estudos Pós-Graduado em Fonoaudiologia, Pontifícia Universidade Católica de São Paulo (PUC-SP), São Paulo, SP, Brazil; Departamento de Fonoaudiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, SP, Brazil.

出版信息

Clinics (Sao Paulo). 2023 Sep 6;78:100281. doi: 10.1016/j.clinsp.2023.100281. eCollection 2023.

DOI:10.1016/j.clinsp.2023.100281
PMID:37683546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10497981/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2823/10497981/21c70613e587/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2823/10497981/21c70613e587/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2823/10497981/21c70613e587/gr1.jpg

相似文献

1
First tonic-clonic seizure five hours after Ad26.COV2.S vaccination without acute brain lesion but long-term chorea.接种Ad26.COV2.S疫苗五小时后首次出现强直阵挛性发作，无急性脑损伤，但有长期舞蹈症。
Clinics (Sao Paulo). 2023 Sep 6;78:100281. doi: 10.1016/j.clinsp.2023.100281. eCollection 2023.
2
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.美国关于 COVID-19 疫苗接种后发生 Guillain-Barré 综合征的报告。
JAMA Netw Open. 2023 Feb 1;6(2):e2253845. doi: 10.1001/jamanetworkopen.2022.53845.
3
Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.同源和异源加强免疫在 Ad26.COV2.S 初免个体中的体液和细胞免疫原性：突破性感染的比较。
Front Immunol. 2023 Mar 7;14:1131229. doi: 10.3389/fimmu.2023.1131229. eCollection 2023.
4
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge.单剂量Ad26.COV2.S疫苗在美国德尔塔变种激增之前及期间预防新冠病毒感染和住院的持久性
JAMA Netw Open. 2022 Mar 1;5(3):e222959. doi: 10.1001/jamanetworkopen.2022.2959.
5
Vaccine-induced immune thrombotic thrombocytopenia in a male after Ad26.COV2.S vaccination presenting as cerebral venous sinus thrombosis.一名男性接种Ad26.COV2.S疫苗后出现疫苗诱导的免疫性血栓性血小板减少症，表现为脑静脉窦血栓形成。
Platelets. 2022 Jul 4;33(5):797-800. doi: 10.1080/09537104.2022.2071854. Epub 2022 May 9.
6
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.美国 Ad26.COV2.S（强生）新型冠状病毒病 2019（COVID-19）疫苗预防 COVID-19 住院和进展为高疾病严重程度的有效性。
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S159-S166. doi: 10.1093/cid/ciac439.
7
Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for the Prevention of COVID-19 among Dialysis Patients.mRNA 疫苗 BNT162b2 与腺病毒载体疫苗 Ad26.COV2.S 预防透析患者 COVID-19 的效果比较。
J Am Soc Nephrol. 2022 Apr;33(4):688-697. doi: 10.1681/ASN.2021101395. Epub 2022 Feb 8.
8
Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans.同源加强剂方案（Ad26.COV2.S 疫苗）接种后人类体内抗体持久性的机制模型预测。
CPT Pharmacometrics Syst Pharmacol. 2023 Oct;12(10):1485-1498. doi: 10.1002/psp4.13025. Epub 2023 Sep 15.
9
Guillain-Barré Syndrome After Ad26.COV2.S Vaccination.接种 Ad26.COV2.S 后出现格林-巴利综合征。
Am J Case Rep. 2022 Feb 14;23:e935275. doi: 10.12659/AJCR.935275.
10
Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine.检测对 Ad26.COV2.S 疫苗无应答的 HIV-1 感染个体中预先存在的针对 Ad26 的中和抗体。
Infection. 2023 Dec;51(6):1657-1667. doi: 10.1007/s15010-023-02035-6. Epub 2023 Apr 17.

本文引用的文献

1
[Cryptogenic new-onset super-refractory status epilepticus following SARS-CoV-2 vaccination. A case report].[新型冠状病毒2型疫苗接种后隐源性新发超难治性癫痫持续状态。一例报告]
Rev Neurol. 2023 Jun 16;76(12):399-402. doi: 10.33588/rn.7612.2022374.
2
Observational Study of Patients Hospitalized With Neurologic Events After SARS-CoV-2 Vaccination, December 2020-June 2021.2020年12月至2021年6月接种SARS-CoV-2疫苗后发生神经系统事件住院患者的观察性研究。
Neurol Clin Pract. 2023 Aug;13(4):e200166. doi: 10.1212/CPJ.0000000000200166. Epub 2023 May 25.
3
Neurological Adverse Reactions to SARS-CoV-2 Vaccines.
新型冠状病毒疫苗的神经不良反应
Clin Psychopharmacol Neurosci. 2023 May 30;21(2):222-239. doi: 10.9758/cpn.2023.21.2.222.
4
Brain lesion locations associated with secondary seizure generalization in tumors and strokes.与肿瘤和中风继发全身性发作相关的脑损伤部位。
Hum Brain Mapp. 2023 Jun 1;44(8):3136-3146. doi: 10.1002/hbm.26268. Epub 2023 Mar 27.
5
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review.COVID-19 疫苗接种后急性播散性脑脊髓炎（ADEM）：系统评价。
J Clin Neurosci. 2023 May;111:57-70. doi: 10.1016/j.jocn.2023.03.008. Epub 2023 Mar 22.
6
Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.与BNT162b2、Ad26.COV2.S和mRNA-1273新冠疫苗相关的严重不良反应：通过疫苗不良事件报告系统（VAERS）深入了解
Front Pharmacol. 2022 Nov 7;13:921760. doi: 10.3389/fphar.2022.921760. eCollection 2022.
7
Spectrum of Neurological Complications Following COVID-19 Vaccination in India.印度新冠疫苗接种后神经系统并发症的范围
J Clin Neurol. 2022 Nov;18(6):681-691. doi: 10.3988/jcn.2022.18.6.681.
8
Acute Necrotizing Encephalitis as an Early Manifestation of COVID-19.急性坏死性脑炎作为新型冠状病毒肺炎的早期表现
Cureus. 2022 Aug 12;14(8):e27928. doi: 10.7759/cureus.27928. eCollection 2022 Aug.
9
New-onset refractory status epilepticus due to autoimmune encephalitis after vaccination against SARS-CoV-2: First case report.接种新型冠状病毒疫苗后因自身免疫性脑炎导致的新发难治性癫痫持续状态：首例病例报告。
Front Neurol. 2022 Aug 16;13:946644. doi: 10.3389/fneur.2022.946644. eCollection 2022.
10
Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine.基于信使核糖核酸的严重急性呼吸综合征冠状病毒2疫苗第二针接种后发生静脉窦血栓形成
Brain Hemorrhages. 2022 Mar;3(1):36-38. doi: 10.1016/j.hest.2021.12.001. Epub 2021 Dec 8.